EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure‐Guided Engineering of a Promiscuous O ‐Methyltransferase for a SAM Regeneration Biocatalysis Platform of Methylated Pharmaceuticals

Xiran Xiong, Jun Song, Shihan Li, Lu Jin, Qi He, Baohui Zhang, Yan Cao, Shanyong Yi, Yanfang Yang, Xiang Li, Juan Li, Wei Huang iD

Advanced Science · 2026

DOI: 10.1002/advs.202517794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xiran Xiong und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China. Hauptthemen laut MEDLINE: Methyltransferases, S-Adenosylmethionine, Protein Engineering. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Program of Science and Technology Innovation Project of Hubei University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

O ‐Methylation catalyzed by plant O ‐methyltransferase plays a crucial role in both drug design and biosynthesis of natural products. However, their practical applications are often restricted by strict substrate specificity and a strong dependence on the expensive methyl donor S‐adenosyl‐L‐methionine (SAM). Herein, an O ‐methyltransferase, SmOMT, is identified from the medicinal plant Selaginella moellendorffii , exhibiting substrate promiscuity and regioselectivity. SmOMT catalyzed the methylation of 25 structurally diverse substrates and demonstrated detectable N ‐methylation activity. Combined ternary complex structure and molecular dynamics studies of SmOMT elucidate its catalytic and regioselectivity mechanisms. A double mutant, SmOMT M2 , with enhanced catalytic activity is obtained based on structural analysis. To overcome SAM dependence, a cascade system for SAM regeneration is successfully constructed by coupling SmOMT M2 with a mutant halide methyltransferase, AtHMT V140T . Employing the iMARS platform, a highly active fusion enzyme, AtHMT V140T ‐L 95 ‐SmOMT M2 , is designed. This fusion enzyme outperforms the free‐enzyme cascade system and facilitates the gram‐scale synthesis of a series of methylated compounds with enhanced anti‐inflammatory activity. This work provides a versatile methylating biocatalyst and establishes an efficient SAM regeneration methylation platform, overcoming limitations in enzymatic methylation and enabling the sustainable production of high‐value pharmaceuticals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesS-AdenosylmethionineProtein EngineeringBiocatalysisMethylationSubstrate Specificity

Stichwörter der Autor:innen

SAM regenerationfusion enzymeplant O‐methyltransferasestructuresubstrate promiscuity

Substanzen

MethyltransferasesS-Adenosylmethionine

Autor:innen und Institutionen

  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
  • Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, Wuhan, China.
  • Traditional Chinese Medicine Institute of Anhui Dabie Mountain, West Anhui University, Luan, China.
  • Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

ORCID-Profile: Wei Huang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province
  • Program of Science and Technology Innovation Project of Hubei University of Chinese Medicine
  • the Key project at central government level: The ability establishment of sustainable use for valuable Chinese medicine resources

Zitieren

APA

Xiong, X., Song, J., Li, S., Jin, L., He, Q., Zhang, B., Cao, Y., Yi, S., Yang, Y., Li, X., Li, J., & Huang, W. (2026). Structure‐Guided Engineering of a Promiscuous O ‐Methyltransferase for a SAM Regeneration Biocatalysis Platform of Methylated Pharmaceuticals. Advanced Science. https://doi.org/10.1002/advs.202517794

Vancouver

Xiong X, Song J, Li S, Jin L, He Q, Zhang B, et al. Structure‐Guided Engineering of a Promiscuous O ‐Methyltransferase for a SAM Regeneration Biocatalysis Platform of Methylated Pharmaceuticals. Advanced Science. 2026. doi:10.1002/advs.202517794

BibTeX
@article{Xiong2026,
  author = {Xiong, Xiran and Song, Jun and Li, Shihan and Jin, Lu and He, Qi and Zhang, Baohui and Cao, Yan and Yi, Shanyong and Yang, Yanfang and Li, Xiang and Li, Juan and Huang, Wei},
  title = {Structure‐Guided Engineering of a Promiscuous O ‐Methyltransferase for a SAM Regeneration Biocatalysis Platform of Methylated Pharmaceuticals},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202517794}
}
Kostenlos starten →